Century Therapeutics Inc Stock price
Is Century Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Century Therapeutics Inc Stock Analysis
Analyst Opinions
12 Analysts have issued a Century Therapeutics Inc forecast:
Analyst Opinions
12 Analysts have issued a Century Therapeutics Inc forecast:
Don't miss a Thing! We will send you all news about Century Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Century Therapeutics Inc Stock News
Company Profile
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It engages in harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.
| Head office | United States |
| CEO | Dr. Pfeiffenberger |
| Employees | 78 |
| Founded | 2018 |
| Website | www.centurytx.com |


